by V Milan-Ortiz 2024amiodarone dose and discharged on amiodarone 400 mg PO BID. The patient was given the following instruction to taper down amiodarone dose
IV amiodarone. ▫ ≤ 24hours on IV amiodarone: start mg po Q12h. ▫ ≥ 48hours on IV amiodarone: start 200mg po q12h. ▫ Decrease the dose by half once
Amiodarone increases PO digoxin serum concentrations by ~70% and IV digoxin by ~17%; measure digoxin levels before initiating amiodarone and reduce PO digoxin dose by %; decrease IV digoxin dose by % amiodarone will increase the level or effect of digoxin by basic (cationic) drug competition for renal tubular clearance. Avoid or Use
Amiodarone increases PO digoxin serum concentrations by ~70% and IV digoxin by ~17%; measure digoxin levels before initiating amiodarone and reduce PO digoxin dose by %; decrease IV digoxin dose by % amiodarone will increase the level or effect of digoxin by basic (cationic) drug competition for renal tubular clearance. Avoid or Use
Up-titrate PO dose if HR 110 after 2 hours from 1st oral dose. 12.5 mg PO Amiodarone PO dosing in hospital. After converts to NSR or after 24 hrs
by U Khanderia 2024 Cited by 19May start amiodarone IV or PO. 6. Amiodarone 150 mg IV bolus (may repeat). 7 PO: 600 mg PO TID x 9 doses, then 200 mg PO daily. FIG. 1 Management and
Amiodarone IV Dosing Amiodarone PO dosing in hospital. After converts to NSR or after 24 hrs, 400mg PO BID up to 10g load (includes IV), then 200mg daily.
Avoid or Use Alternate Drug. Amiodarone increases PO digoxin serum concentrations by ~70% and IV digoxin by ~17%; measure digoxin levels before initiating amiodarone and reduce PO digoxin dose by %; decrease IV digoxin dose by % amiodarone will increase the level or effect of digoxin by basic (cationic) drug competition for renal
Amiodarone increases PO digoxin serum concentrations by ~70% and IV digoxin by ~17%; measure digoxin levels before initiating amiodarone and reduce PO digoxin dose by %; decrease IV digoxin dose by % amiodarone will increase the level or effect of digoxin by basic (cationic) drug competition for renal tubular clearance. Avoid or Use
Comments
Boyd